Skip to main content

Table 4 The genotypes of MUC5B promoter polymorphism as regards the smoking status among the 3 studied groups

From: A preliminary study: MUC5B promoter polymorphism and its association with IPF

Genotype

Smokers

Non smokers

P value

IPF patients (group I)

   

GT and TT

13 (50%)

13 (50%)

0.014

GG

2 (12.5%)

14 (87.5)

 

Other ILD patients (group II)

   

GT and TT

2 (11.8%)

15 (88.2%)

0.850

GG

3 (10%)

27 (90%)

 

Control subjects (group III)

   

GT and TT

2 (25%)

6 (75%)

0.650

GG

6 (18.8%)

26 (81.3%)